Association between serum estradiol level and coronary artery calcification in postmenopausal women

Menopause

Volumn 17, Issue 5, 2010, Pages 902-907

  Jeon, Gyun Ho ^a,b   Kim, Sung Hoon ^a   Yun, Sung Cheol ^a   Chae, Hee Dong ^a   Kim, Chung Hoon ^a   Kang, Byung Moon ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

Cardiovascular; Coronary artery calcification; Estradiol; Postmenopause

Indexed keywords

ESTRADIOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTERY CALCIFICATION; ARTICLE; BONE DENSITY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY RISK; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR NECK; HORMONAL THERAPY; HUMAN; ISCHEMIC HEART DISEASE; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; POSTMENOPAUSE; SCORING SYSTEM;

AGED; CALCINOSIS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; ESTRADIOL; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77957694666     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181d76768     Document Type: Article

References (36)

1. Hodis HN, Mack WJ, Lobo R. Antiatherosclerosis interventions in women. Am J Cardiol 2002;90:17F-21F.
2. Sullivan JM, Vander Zwaag R, Lemp GF, et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988;108:358-363.
3. Grodstein F, Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995;38:199-210.
4. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811.
5. Sourander L, Rajala T, Raiha I, et al. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT). Lancet 1999;352:1965-1969
6. Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199-208.
7. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003;289:2673-2684.
8. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712.
9. Haberl R, Becker A, Leber A, et al. Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients. J Am Coll Cardiol 2001;37:451-457.
10. Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 2006;114:1761-1791.
11. Arad Y, Spadaro LA, Goodman K, et al. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 2000;36: 1253-1260.
12. Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004;291:210-215.
13. Wexler L, Brundage B, Crouse J, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. Circulation 1996;94:1175-1192.
14. Arad Y, Spadaro LA, Goodman K, et al. Predictive value of electron beam computed tomography of the coronary arteries. 19-Month follow-up of 1173 asymptomatic subjects. Circulation 1996;93:1951-1953.
15. Manson JE, Allison MA, Rossouw JE, et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007;356:2591-2602.
16. Barrett-Connor E, Laughlin GA. Hormone therapy and coronary artery calcification in asymptomatic postmenopausal women: the Rancho Bernardo Study. Menopause 2005;12:40-48. (Pubitemid 40204892)
17. Akhrass F, Evans AT, Wang Y, et al. Hormone replacement therapy is associated with less coronary atherosclerosis in postmenopausal women. J Clin Endocrinol Metab 2003;88:5611-5614.
18. Becker A, Leber A, von Ziegler F, et al. Comparison of progression of coronary calcium in postmenopausal women on versus not on estrogen/progestin therapy. Am J Cardiol 2007;99:374-378.
19. Schisterman EF, Gallagher AM, Bairey Merz CN, et al. The association of hormone replacement therapy and coronary calcium as determined by electron beam tomography. J Womens Health Gend Based Med 2002; 11:631-638.
20. Silva TC, Barrett-Connor E, Ramires JA, et al. Obesity, estrone, and coronary artery disease in postmenopausal women. Maturitas 2008;59: 242-248.
21. Carr JJ, Nelson JC, Wong ND, et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 2005;234:35-43.
22. Rumberger JA, Sheedy PF, Breen JF, et al. Electron beam computed tomography and coronary artery disease: scanning for coronary artery calcification. Mayo Clin Proc 1996;71:369-377.
23. Gruber CJ, Tschugguel W, Schneeberger C, et al. Production and actions of estrogens. N Engl J Med 2002;346:340-352.
24. Robins J, Hernan M, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000;11:550-560.
25. Adams MR, Kaplan JR, Manuck SB, et al. Inhibition of coronary artery atherosclerosis by 17-A estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 1990;10:1051-1057.
26. Adams MR, Register TC, Golden DL, et al. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:217-221.
27. Grodstein F, Manson JE, Colditz GA, et al. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933-941.
28. Joakimsen O, BLnaa KH, Stensland-Bugge E, et al. Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis: the TromsL Study. J Clin Epidemiol 2000;53:525-530.
29. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75: 1102-1109.
30. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J 1996;10:615-624.
31. Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002;53:605-619.
32. Hodis HN, Mack WJ, Lobo RA, et al. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001;135:939-953.
33. Barengolts EI, Berman M, Kukreja SC, et al. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 1998;62:209-213.
34. Sinnott B, Syed I, Sevrukov A, et al. Coronary calcification and osteoporosis in men and postmenopausal women are independent processes associated with aging. Calcif Tissue Int 2006;78:195-202.
35. Farhat GN, Strotmeyer ES, Newman AB, et al. Volumetric and areal bone mineral density measures are associated with cardiovascular disease in older men and women: the health, aging, and body composition study. Calcif Tissue Int 2006;79:102-111.
36. Choi SH, An JH, Lim S, et al. Lower bone mineral density is associated with higher coronary calcification and coronary plaque burdens by multi-detector row coronary computed tomography in pre-and postmenopausal women. Clin Endocrinol (Oxf) 2009;71:644-651.